Literature DB >> 24961619

Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia.

Robert I Henkin1, Samuel J Potolicchio2, Lucien M Levy3.   

Abstract

Olfactory hallucinations without subsequent myoclonic activity have not been well characterized or understood. Herein we describe, in a retrospective study, two major forms of olfactory hallucinations labeled phantosmias: one, unirhinal, the other, birhinal. To describe these disorders we performed several procedures to elucidate similarities and differences between these processes. From 1272, patients evaluated for taste and smell dysfunction at The Taste and Smell Clinic, Washington, DC with clinical history, neurological and otolaryngological examinations, evaluations of taste and smell function, EEG and neuroradiological studies 40 exhibited cyclic unirhinal phantosmia (CUP) usually without hyposmia whereas 88 exhibited non-cyclic birhinal phantosmia with associated symptomology (BPAS) with hyposmia. Patients with CUP developed phantosmia spontaneously or after laughing, coughing or shouting initially with spontaneous inhibition and subsequently with Valsalva maneuvers, sleep or nasal water inhalation; they had frequent EEG changes usually ipsilateral sharp waves. Patients with BPAS developed phantosmia secondary to several clinical events usually after hyposmia onset with few EEG changes; their phantosmia could not be initiated or inhibited by any physiological maneuver. CUP is uncommonly encountered and represents a newly defined clinical syndrome. BPAS is commonly encountered, has been observed previously but has not been clearly defined. Mechanisms responsible for phantosmia in each group were related to decreased gamma-aminobutyric acid (GABA) activity in specific brain regions. Treatment which activated brain GABA inhibited phantosmia in both groups.

Entities:  

Year:  2013        PMID: 24961619      PMCID: PMC4061890          DOI: 10.3390/brainsci3041483

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  376 in total

Review 1.  The biology of pro-thyrotropin-releasing hormone-derived peptides.

Authors:  E A Nillni; K A Sevarino
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

Review 2.  Search for pathophysiology of panic disorder.

Authors:  P P Roy-Byrne; D S Cowley
Journal:  Lancet       Date:  1998-11-21       Impact factor: 79.321

3.  Abnormalities of taste and smell after head trauma.

Authors:  P J Schechter; R I Henkin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-07       Impact factor: 10.154

Review 4.  Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity.

Authors:  S Nakanishi
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

5.  An olfactory reference syndrome -- monosymptomatic hypochondriasis.

Authors:  E R Bishop
Journal:  J Clin Psychiatry       Date:  1980-02       Impact factor: 4.384

6.  The GABAB agonist baclofen modifies cocaine self-administration in rats.

Authors:  M Shoaib; L S Swanner; C E Beyer; S R Goldberg; C W Schindler
Journal:  Behav Pharmacol       Date:  1998-05       Impact factor: 2.293

7.  Taste and smell function in chronic disease: a review of clinical and biochemical evaluations of taste and smell dysfunction in over 5000 patients at The Taste and Smell Clinic in Washington, DC.

Authors:  Robert I Henkin; Lucien M Levy; April Fordyce
Journal:  Am J Otolaryngol       Date:  2013-06-02       Impact factor: 1.808

8.  Antisense inhibition of striatal GABAA receptor proteins decreases GABA-stimulated chloride uptake and increases cocaine sensitivity in rats.

Authors:  J Peris; B J Jung; A Resnick; P Walker; O Malakhova; Y Bokrand; D Wielbo
Journal:  Brain Res Mol Brain Res       Date:  1998-06-15

9.  Comparison of the effects of independently-controlled end-tidal PCO(2) and PO(2) on blood oxygen level-dependent (BOLD) MRI.

Authors:  Eitan Prisman; Marat Slessarev; Jay Han; Julien Poublanc; Alexandra Mardimae; Adrian Crawley; Joseph Fisher; David Mikulis
Journal:  J Magn Reson Imaging       Date:  2008-01       Impact factor: 4.813

10.  Emotional dysregulation, alexithymia, and attachment in psychogenic nonepileptic seizures.

Authors:  Richard J Brown; Julia F Bouska; Anna Frow; Antonia Kirkby; Gus A Baker; Steven Kemp; Christine Burness; Markus Reuber
Journal:  Epilepsy Behav       Date:  2013-08-22       Impact factor: 2.937

View more
  7 in total

1.  Phantosmia and Dysgeusia following Endoscopic Transcribriform Approaches to Olfactory Groove Meningiomas.

Authors:  Andrew S Venteicher; Jay I Kumar; Emma A Murphy; Stacey T Gray; Eric H Holbrook; William T Curry
Journal:  J Neurol Surg B Skull Base       Date:  2017-01-18

Review 2.  No Laughing Matter: Gelastic Migraine and Other Unusual Headache Syndromes.

Authors:  Paul G Mathew; Carrie E Robertson
Journal:  Curr Pain Headache Rep       Date:  2016-05

3.  The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.

Authors:  Nolwen L Rey; Daniel W Wesson; Patrik Brundin
Journal:  Neurobiol Dis       Date:  2016-12-20       Impact factor: 5.996

4.  Phantosmia Among Pediatric, Adolescent, and Young Adult Patients Receiving Proton Beam Therapy.

Authors:  Shoshana J Rosenzweig; Stanislav Lazarev; Shaakir Hasan; Jana Fox; J Isabelle Choi; Charles B Simone; Suzanne L Wolden
Journal:  Adv Radiat Oncol       Date:  2021-12-25

5.  [Osmophobia and vestibular migraine]

Authors:  Alejandro Garcia; Sebastian Rivera Retamal; Bernardita Alvear; Melissa Castillo-Bustamante
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2022-03-07

Review 6.  Pathophysiology and Therapy of Associated Features of Migraine.

Authors:  Maria Dolores Villar-Martinez; Peter J Goadsby
Journal:  Cells       Date:  2022-09-05       Impact factor: 7.666

Review 7.  Anosmia: A review in the context of coronavirus disease 2019 and orofacial pain.

Authors:  Davis C Thomas; Sita Mahalakshmi Baddireddy; Divya Kohli
Journal:  J Am Dent Assoc       Date:  2020-07-01       Impact factor: 3.634

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.